Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Dynamic Linkage between Provirus Integration Sites and the Host Functional Genome Property Alongside HIV-1 Infections Associated with Antiretroviral Therapy. | Vaccines (Basel) | 2023 | 36851277 | PubTator, text mining | PubMed |
| Challenges and optimal strategies of CAR T therapy for hematological malignancies. | Chin Med J (Engl) | 2023 | 36848181 | PubTator, text mining | PubMed |
| CD203c is expressed by human fetal hepatoblasts and distinguishes subsets of hepatoblastoma. | Front Oncol | 2023 | 36845728 | PubTator, text mining | PubMed |
| The immune-metabolic crosstalk between CD3+C1q+TAM and CD8+T cells associated with relapse-free survival in HCC. | Front Immunol | 2023 | 36845133 | PubTator, text mining | PubMed |
| Secondary involvement of gallbladder by acute lymphoblastic leukemia presenting clinically as cholecystitis in a young patient: a case report. | World J Surg Oncol | 2023 | 36843105 | PubTator, text mining | PubMed |
| The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia. | J Clin Med | 2023 | 36835986 | PubTator, text mining | PubMed |
| Accumulated precursors of specific GPI-anchored proteins upregulate GPI biosynthesis with ARV1. | J Cell Biol | 2023 | 36828365 | PubTator, text mining | PubMed |
| Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models. | J Immunother Cancer | 2023 | 36822670 | PubTator, text mining | PubMed |
| A novel human multiple myeloma cell line with a 1q21 gain genetic abnormality and CKS1B overexpression. | Ann Transl Med | 2023 | 36819558 | PubTator, text mining | PubMed |
| Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling. | Br J Cancer | 2023 | 36810912 | PubTator, text mining | PubMed |
| T-cell antigen recognition: catch-as-catch-can or catch-22? | EMBO J | 2023 | 36808636 | PubTator, text mining | PubMed |
| Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume. | CNS Neurosci Ther | 2023 | 36807865 | PubTator, text mining | PubMed |
| Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination. | Clin Exp Immunol | 2023 | 36807499 | PubTator, text mining | PubMed |
| Plasma proteome dynamics of COVID-19 severity learnt by a graph convolutional network of multi-scale topology. | Life Sci Alliance | 2023 | 36806094 | PubTator, text mining | PubMed |
| HTLV-1 persistence and the oncogenesis of adult T-cell leukemia/lymphoma. | Blood | 2023 | 36800643 | PubTator, text mining | PubMed |
Double systemic cytokine release syndrome following sequential infusion of anti-CD22 and anti-CD19 chimeric antigen receptor T cells after autologous hematopoietic stem cell transplantation for a central diffuse large B-cell lymphoma patient: A case report and literature review. | Front Immunol | 2023 | 36798130 | PubTator, text mining | PubMed |
| Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis. | Front Genet | 2023 | 36793897 | PubTator, text mining | PubMed |
| Research Progress of Tumor Microenvironment Targeted Therapy for Clear Cell Renal Cell Carcinoma. | Cancer Control | 2023 | 36772805 | PubTator, text mining | PubMed |
| Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies-A Critical Overview. | Nutrients | 2023 | 36771465 | PubTator, text mining | PubMed |
| The Immunology of DLBCL. | Cancers (Basel) | 2023 | 36765793 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=20